封面
市場調查報告書
商品編碼
1449650

脂肪醯胺市場:依產品類型、依型態、按地區

Fatty Amides Market, By Product Type (Erucamide, Oleamide, Stearamide, Behenamide), By Form (Powder, Beads, Micro-beads, Pastilles), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024年脂肪醯胺市場規模為4.282億美元,預計2024年至2031年年複合成長率為4.1%,2031年達到5.681億美元。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 4.282 億美元
實際資料 2019-2023 預測期 2024-2031
預測期間2023/2024 至2030/2031年年複合成長率: 4.10% 2030/2031價值預測 5.681 億美元
圖 1. 脂肪醯胺市場區域佔有率(%),2024年
脂肪醯胺市場-IMG1

近年來,由於塑膠、橡膠和油漆等各種最終用途行業的應用不斷擴大,全球脂肪醯胺市場出現了顯著成長。脂肪醯胺在這些行業中主要用作潤滑劑、助流劑和防噴霜劑。脂肪醯胺具有優良的性能,如良好的熱穩定性、耐化學性和寬的液體範圍。此外,再生動植物來源的脂肪醯胺有助於減少對石油產品的依賴,促進市場成長。然而,原物料價格波動仍然是一個關鍵挑戰。然而,人們對生物基化學品的永續性和優勢的認知不斷提高,日益擴大脂肪醯胺製造商的商機。脂肪醯胺,通常稱為脂肪酸醯胺,是有機脂肪酸的衍生物,其中OH基團被NH2(胺)基取代。依產品類型,脂肪醯胺分為Erucamide、油醯胺、硬脂醯胺和Behenamide。含有脂肪醯胺的產品以珠子、粉末狀,有時還有錠劑的形式出售。

市場動態:

全球脂肪醯胺市場的成長是由塑膠和橡膠行業的成長以及生物基化學品的廣泛普及導致的需求增加等因素所推動的。脂肪醯胺在塑膠和橡膠配方中主要用作潤滑劑、脫模劑和防粘連劑。此外,對高性能產品的需求不斷成長推動脂肪醯胺的消費。然而,價格波動和棕櫚油、椰子油、Tall oil原料供應不穩定是主要挑戰。此外,有關石化產品排放的嚴格環境法規限制市場成長。另一方面,永續性和對生物基化學品不斷變化的偏好帶來了巨大的機會。領先公司投資研發,以開發新的應用領域和環保生產技術。

本研究的主要特點

  • 本報告對脂肪醯胺市場進行了詳細分析,並提供了以2023年為基準年的預測期(2024-2031)的市場規模和年複合成長率(CAGR%)。
  • 強調了各個細分市場的潛在收益成長機會,並為該市場說明了一系列有吸引力的投資提案。
  • 提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 根據公司亮點、產品系列、主要亮點、財務業績和策略等參數,對脂肪醯胺市場的主要企業進行了介紹。
  • 本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 脂肪醯胺市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規及趨勢分析

  • 市場動態
  • 個人護理行業需求增加
  • 替代品的可用性
  • 利基泡沫的脂肪酸醯胺創新
  • 主要亮點
  • 監管場景
  • 最近的趨勢
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 合併、收購和合作

第4章 脂肪醯胺市場-冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章 脂肪醯胺市場,依產品類型,2019-2031

  • Erucamide
  • 硬脂醯胺
  • Behenamide
  • 油酸醯胺

第6章 脂肪醯胺市場,依型態分類,2019-2031

  • 粉末、珠子
  • 微珠
  • 菱形

第7章 脂肪​​醯胺市場,依地區,2019-2031

  • 2024年及2031年依地區分類的市場佔有率分析(%)
  • 2020-2031與前一年同期比較成長分析(依地區)
  • 各國的趨勢
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東、非洲
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 南非
  • 中部非洲
  • 北非

第8章 競爭格局

  • 公司簡介
    • Lonza
    • Novartis International AG
    • BASF AG
    • SEQENS
    • Carbogen Amcis AG
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd
    • Bristol-Myers Squibb
    • Pfizer Inc.
    • Roche Diagnostics
    • Boehringer Ingelheim
    • Merck &Co
    • Bayer AG
    • Ajinomoto Bio-Pharma Services
    • Cambrex Corporation
    • Minakem
    • Sanofi Aventis

第9章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI3486

The fatty amides Market size is valued at US$ 428.2 Mn in 2024 and is expected to reach US$ 568.1 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 428.2 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 4.10% 2030/2031 Value Projection: US$ 568.1 Mn
Figure 1. Fatty Amides Market Share (%), by Region, 2024
Fatty Amides Market - IMG1

The global fatty amides market has been witnessing significant growth in recent years driven by growing applications in various end-use industries such as plastics, rubber, coatings, and others. Fatty amides are mainly used as lubricants, flow promoters, and anti-blooming agents in these industries. They offer excellent properties such as outstanding thermal stability, chemical resistance, and wide liquid range. Additionally, fatty amides derived from renewable plant and animal sources help reduce dependency on petroleum-based products, thereby boosting the market growth. However, fluctuations in raw material prices remain a key challenge. But growing awareness about sustainability and benefits of bio-based chemicals is expanding opportunities for fatty amides manufacturers. Fatty amides, often termed fatty acid amides, are derivatives of organic fatty acids where an OH group is replaced by an NH2 (amine) group. Depending on the type of product, fatty amides are differentiated as erucamides, oleamides, stearamides, and behenamides. Products containing fatty amides are available in beads, powders, and sometimes also the pastilles form.

Market Dynamics:

The growth of the global fatty amides market is driven by factors such as increasing the demand from the thriving plastics and rubber industries and widespread adoption of bio-based chemicals. Fatty amides find major applications as lubricants, release agents, and anti-blocking agents in plastics and rubber formulations. Additionally, the growing need for high-performance products is propelling the consumption of fatty amides. However, fluctuations in prices and unreliable supply of raw materials such as palm oil, coconut oil, and tall oil pose a major challenge. Furthermore, strict environmental regulations regarding emissions from petrochemical-based products restrain the market growth. Meanwhile, shifting preference toward sustainability and bio-based chemicals presents significant opportunities. Leading players are investing in R&D to develop novel application areas and green production technologies.

Key Features of the Study:

  • This report provides an in-depth analysis of the fatty amides market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the fatty amides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Haihang Industries Co. Ltd., Croda International Plc., PMC Biogenix Inc., Fine Organic Industries Pvt. Ltd., Nippon Fine Chemicals Co., Ltd., Kao Corporation, Italmatch Chemicals S.p.A., Sichuan Tianyu Oleochemical Co., Ltd., and Nippon Kasei Chemical Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The fatty amides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

  • Fatty Amides Market, By Product Type
    • Erucamides
    • Oleamides
    • Stearamides
    • Behenamides
  • Fatty Amides Market, By Form
    • Powder, Beads
    • Micro-beads
    • Pastilles
  • Fatty Amides Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in the Fatty Amides Market:
    • Haihang Industries Co. Ltd.
    • Croda International Plc.
    • PMC Biogenix Inc.
    • Fine Organic Industries Pvt. Ltd.
    • Nippon Fine Chemicals Co., Ltd.
    • Kao Corporation
    • Italmatch Chemicals S.p.A.
    • Sichuan Tianyu Oleochemical Co., Ltd.
    • Nippon Kasei Chemical Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Fatty Amides Market, By Product Type
    • Fatty Amides Market, By Form
    • Fatty Amides Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand from the personal care industry
    • Restraints
  • Availability of substitutes
    • Opportunities
  • Innovation of fatty amides for niche Forms
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Fatty Amides Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Fatty Amides Market, By Product Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Erucamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Stearamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Behenamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Oleamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Fatty Amides Market, By Form , 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Powder, Beads
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Micro-beads
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Pastilles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Fatty Amides Market , By Region, 2019-2031, (US$ Mn)

  • Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020 - 2031
  • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Form, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • South Africa
  • Central Africa
  • North Africa

8. Competitive Landscape

  • Company Profile
    • Lonza
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Novartis International AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • BASF AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • SEQENS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Carbogen Amcis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Teva Pharmaceutical Industries Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Bristol-Myers Squibb
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Boehringer Ingelheim
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Merck & Co
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Ajinomoto Bio-Pharma Services
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Cambrex Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Minakem
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Sanofi Aventis
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us